Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Svt-40776
1. 385367-47-5
2. Tarafenacin [inn]
3. Ldv98un52y
4. Chembl1779046
5. Svt-40776
6. Unii-ldv98un52y
7. (3r)-1-azabicyclo[2.2.2]octan-3-yl (3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]carbamate
8. (3r)-1-azabicyclo(2.2.2)octan-3-yl (3-fluorophenyl)((3,4,5-trifluorophenyl)methyl)carbamate
9. Tarafenacin(svt-40776)
10. Tarafenacin [who-dd]
11. Schembl2278264
12. Ex-a209
13. Dtxsid301319099
14. Zinc3965738
15. Bdbm50344283
16. Mfcd19443715
17. (3r)-1-az2,4(1habicyclo(2.2.2)octan-3-yl (3-fluorophenyl)((3,4,5-trifluorophenyl)methyl)carbamate
18. Ac-30285
19. Hy-14825
20. J-690291
21. Q27282936
22. (r)-quinuclidin-3-yl 3-fluorophenyl(3,4,5-trifluorobenzyl)carbamate
23. (3r)-(3-fluorophenyl)-(3,4,5-trifluorobenzyl)carbamic Acid 1-aza-bicyclo[2.2.2]oct-3-yl Ester
24. (3r)-1-azabicyclo[2.2.2]octan-3-yl N-(3-fluorophenyl)-n-[(3,4,5-trifluorophenyl)methyl]carbamate
25. [(3r)-1-azabicyclo[2.2.2]octan-3-yl] N-(3-fluorophenyl)-n-[(3,4,5-trifluorophenyl)methyl]carbamate
| Molecular Weight | 408.4 g/mol |
|---|---|
| Molecular Formula | C21H20F4N2O2 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 408.14609053 g/mol |
| Monoisotopic Mass | 408.14609053 g/mol |
| Topological Polar Surface Area | 32.8 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 563 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
100
PharmaCompass offers a list of Tarafenacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tarafenacin manufacturer or Tarafenacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tarafenacin manufacturer or Tarafenacin supplier.
PharmaCompass also assists you with knowing the Tarafenacin API Price utilized in the formulation of products. Tarafenacin API Price is not always fixed or binding as the Tarafenacin Price is obtained through a variety of data sources. The Tarafenacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tarafenacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tarafenacin, including repackagers and relabelers. The FDA regulates Tarafenacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tarafenacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tarafenacin supplier is an individual or a company that provides Tarafenacin active pharmaceutical ingredient (API) or Tarafenacin finished formulations upon request. The Tarafenacin suppliers may include Tarafenacin API manufacturers, exporters, distributors and traders.
Tarafenacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tarafenacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tarafenacin GMP manufacturer or Tarafenacin GMP API supplier for your needs.
A Tarafenacin CoA (Certificate of Analysis) is a formal document that attests to Tarafenacin's compliance with Tarafenacin specifications and serves as a tool for batch-level quality control.
Tarafenacin CoA mostly includes findings from lab analyses of a specific batch. For each Tarafenacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tarafenacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tarafenacin EP), Tarafenacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tarafenacin USP).
